Loading...
Measurement of coagulation factors during rivaroxaban and apixaban treatment: Results from two crossover trials
BACKGROUND: Prediction models for venous thromboembolism recurrence will likely be improved by adding levels of coagulation factors. Risk assessment is ideally performed during anticoagulant treatment, however, the influence of direct oral anticoagulants on coagulation factors is uncertain. OBJECTIV...
Na minha lista:
| Udgivet i: | Res Pract Thromb Haemost |
|---|---|
| Main Authors: | , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
John Wiley and Sons Inc.
2018
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6178718/ https://ncbi.nlm.nih.gov/pubmed/30349888 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/rth2.12142 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|